Status:
COMPLETED
Drug Combination on Exercise Performance at High Altitude
Lead Sponsor:
University of Montana
Conditions:
Acute Mountain Sickness
Eligibility:
MALE
18-45 years
Phase:
PHASE2
PHASE3
Brief Summary
This study is being conducted to determine the effectiveness of using two FDA approved medications in concert to reduce the likelihood of sickness due to low oxygen levels and to reduce the decrement ...
Eligibility Criteria
Inclusion
- healthy males
Exclusion
- VO2max below 45ml/kg/min
- currently taking any medication
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT01902758
Start Date
August 1 2013
End Date
August 1 2013
Last Update
February 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montana Center for Work Physiology and Exercise Metabolism
Missoula, Montana, United States, 59812